Table 3 Demographic Characteristics by APOE4 status (N)
| Â | APOE4(-) | APOE4(+) | p-value* |
|---|---|---|---|
Mean Age | 76.2 (54) | 76.5 (68) | 0.796 |
Mean ADAS-Cog | 21.9 (59) | 23.4 (69) | 0.273 |
Mean MMSE | 20.3 (55) | 19.4 (70) | 0.239 |
Sex | F 59% (37) | F 53% (38) | Â |
F = female, M = male | M 41% (26) | M 47% (34) | 0.603 |
Donepezil | N 60% (38) | N 47% (34) | Â |
| Â | Y 40% (25) | Y 53% (38) | 0.167 |
Memantine | N 70% (44) | N 50% (36) | 0.023 |
| Â | Y 30% (19) | Y 50% (36) | Â |
Galantamine | N 95% (60) | N 92% (66) | 0.502 |
| Â | Y 5% (3) | Y 8% (6) | Â |
Number of AD medications | 0 – 30% (19) | 0 – 15% (11) |  |
|  | 1 – 51% (32) | 1 – 44% (32) |  |
|  | 2 – 19% (12) | 2 – 40% (29) | 0.012†|
Completed study | N 37% (23) | N 33% (24) | 0.721 |
| Â | Y 63% (40) | Y 67% (48) | Â |